Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Increasing resistance of Staphylococcus aureus to ciprofloxacin.

Literature DB >> 2285306

Increasing resistance of Staphylococcus aureus to ciprofloxacin.

T E Daum¹, D R Schaberg, M S Terpenning, W S Sottile, C A Kauffman.

Abstract

We demonstrated the marked emergence of resistance to ciprofloxacin among Staphylococcus arueus strains isolated at the Ann Arbor Veterans Administration Medical Center. All S. aureus isolates tested from 1984 to 1985 were susceptible, whereas 55.1% of methicillin-resistant and 2.5% of methicillin-susceptible strains from 1989 had high-level resistance to ciprofloxacin.

Entities: Chemical Species

Mesh：

Substances：
Ciprofloxacin

Year: 1990 PMID： 2285306 PMCID： PMC171950 DOI： 10.1128/AAC.34.9.1862

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

11 in total

1. Emergence of ciprofloxacin-resistant coagulase-negative staphylococcal skin flora in immunocompromised patients receiving ciprofloxacin.

Authors: P Kotilainen; J Nikoskelainen; P Huovinen
Journal: J Infect Dis Date: 1990-01 Impact factor: 5.226

2. Staphylococcus aureus nasal colonization in a nursing home: eradication with mupirocin.

Authors: J E Cederna; M S Terpenning; M Ensberg; S F Bradley; C A Kauffman
Journal: Infect Control Hosp Epidemiol Date: 1990-01 Impact factor: 3.254

3. Ciprofloxacin: an overview and prospective appraisal.

Authors: H C Neu
Journal: Am J Med Date: 1987-04-27 Impact factor: 4.965

4. Ciprofloxacin-resistant Staphylococcus aureus.

Authors: H Humphreys; E Mulvihill
Journal: Lancet Date: 1985-08-17 Impact factor: 79.321

5. Ciprofloxacin resistance in methicillin- and gentamicin-resistant Staphylococcus aureus.

Authors: P Maple; J Hamilton-Miller; W Brumfitt
Journal: Eur J Clin Microbiol Infect Dis Date: 1989-07 Impact factor: 3.267

6. Ciprofloxacin for eradication of methicillin-resistant Staphylococcus aureus colonization.

Authors: M E Mulligan; P J Ruane; L Johnston; P Wong; J P Wheelock; K MacDonald; J F Reinhardt; C C Johnson; B Statner; I Blomquist
Journal: Am J Med Date: 1987-04-27 Impact factor: 4.965

7. Successful use of broth microdilution in susceptibility tests for methicillin-resistant (heteroresistant) staphylococci.

Authors: C Thornsberry; L K McDougal
Journal: J Clin Microbiol Date: 1983-11 Impact factor: 5.948

8. The effect of ciprofloxacin on methicillin-resistant Staphylococcus aureus.

Authors: S M Smith; R H Eng; E Berman
Journal: J Antimicrob Chemother Date: 1986-03 Impact factor: 5.790

9. Methicillin-resistant strains of Staphylococcus aureus resistant to quinolones.

Authors: S Schaefler
Journal: J Clin Microbiol Date: 1989-02 Impact factor: 5.948

Review 10. Fluoroquinolone antimicrobial agents.

Authors: J S Wolfson; D C Hooper
Journal: Clin Microbiol Rev Date: 1989-10 Impact factor: 26.132

33 in total

1. In vitro antibiotic resistance in bacterial keratitis in London.

Authors: S J Tuft; M Matheson
Journal: Br J Ophthalmol Date: 2000-07 Impact factor: 4.638

2. Spontaneously occurring staphylococcal mutants resistant to clinically achievable concentrations of ciprofloxacin and temafloxacin.

Authors: A L Barry; M A Pfaller; P C Fuchs
Journal: Eur J Clin Microbiol Infect Dis Date: 1992-03 Impact factor: 3.267

3. Increasing resistance of enterococci to ciprofloxacin.

Authors: D R Schaberg; W I Dillon; M S Terpenning; K A Robinson; S F Bradley; C A Kauffman
Journal: Antimicrob Agents Chemother Date: 1992-11 Impact factor: 5.191

4. Antistaphylococcal activity of the fluoroquinolones CI-960, PD 131628, sparfloxacin, ofloxacin and ciprofloxacin.

Authors: A L Barry; P C Fuchs
Journal: Eur J Clin Microbiol Infect Dis Date: 1991-03 Impact factor: 3.267

5. Activity of new quinolones against ciprofloxacin-resistant staphylococci.

Authors: G J Forstall; C C Knapp; J A Washington
Journal: Antimicrob Agents Chemother Date: 1991-08 Impact factor: 5.191

6. Diversity in the antimicrobial susceptibility patterns of methicillin-resistant Staphylococcus aureus clones.

Authors: E Ghaznavi-Rad; V Neela; M Nor Shamsudin; H Ghasemzadeh Moghaddam; M Tavakol; A van Belkum; M R Etemadi; A F Andar-Ali
Journal: Eur J Clin Microbiol Infect Dis Date: 2012-07-25 Impact factor: 3.267

Review 7. The use of quinolones in developing countries.

Authors: E Rodríguez-Noriega; R Morfin-Otero; S Esparza-Ahumada
Journal: Drugs Date: 1993 Impact factor: 9.546

8. A prospective, randomized study of pefloxacin versus teicoplanin in the treatment of gram-positive coccal infections in cancer patients: early termination due to emergence of resistance to fluoroquinolones.

Authors: M Aoun; P Van der Auwera; I Varthalitis; A M Bourguignon; M Janssen; D Daneau; F Meunier
Journal: Support Care Cancer Date: 1994-05 Impact factor: 3.603

9. Study of Stomatococcus mucilaginosus isolated in a hospital ward using phenotypic characterization.

Authors: F H van Tiel; B F Slangen; H C Schouten; J A Jacobs
Journal: Eur J Clin Microbiol Infect Dis Date: 1995-03 Impact factor: 3.267

10. Methicillin-resistant Staphylococcus aureus nosocomial infection trends in Hospital Universiti Sains Malaysia during 2002-2007.

Authors: Hassanain I Al-Talib; Chan Y Yean; Karim Al-Jashamy; Habsah Hasan
Journal: Ann Saudi Med Date: 2010 Sep-Oct Impact factor: 1.526